Senores Pharmaceuticals informs about outcome of board meeting

02 Jun 2025 Evaluate

In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Senores Pharmaceuticals has informed that on recommendation of the Audit Committee, the Board of Directors of the Company at their Meeting held today Monday, June 02, 2025, has appointed Sharp & Tannan Associates, Chartered Accountants (Firm Registration No. 109983W) as the Internal Auditor of the Company for FY 2025-26. The details as required under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, is given in the Annexure?A. The meeting of Board of Directors of the Company commenced at 12:15 pm (IST) and concluded at 01:40 pm (IST). This intimation and aforesaid information are also being uploaded on the Company’s website at www.senorespharma.com.

The above information is a part of company’s filings submitted to BSE.


Senores Pharmaceutic Share Price

777.40 -6.85 (-0.87%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×